[Plasma and urinary CEA-assay in patients with urological tumours (author's transl)]
- PMID: 1006894
[Plasma and urinary CEA-assay in patients with urological tumours (author's transl)]
Abstract
Plasma and urinary carcino-embryonic antigen (CEA) assays were performed in 151 patients with urological tumours. CEA measurement is unreliable in renal cell carcinoma and carcinoma of the prostate. However, CEA-assays permit the diagnosis of bladder tumours. The test is particularly useful in the followup and therapeutic control of patients with carcinoma of the bladder.
Similar articles
-
[Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].Helv Chir Acta. 1976 Jul;43(3):271-8. Helv Chir Acta. 1976. PMID: 947865 German.
-
[Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].Gan To Kagaku Ryoho. 1984 May;11(5):1078-83. Gan To Kagaku Ryoho. 1984. PMID: 6721513 Japanese.
-
Carcinoembryonic antigen and urothelial carcinoma.Br J Urol. 1973 Feb;45(1):88-92. Br J Urol. 1973. PMID: 4690154 No abstract available.
-
Immunologic features of genitourinary cancer.Urology. 1973 Aug;2(2):103-8. doi: 10.1016/0090-4295(73)90239-2. Urology. 1973. PMID: 4129366 Review. No abstract available.
-
[Synchronous triple urogenital cancer (renal cancer, bladder cancer, prostatic cancer): a case report].Hinyokika Kiyo. 2002 Apr;48(4):239-42. Hinyokika Kiyo. 2002. PMID: 12048939 Review. Japanese.
Cited by
-
Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.Urol Res. 1985;13(2):55-9. doi: 10.1007/BF00261566. Urol Res. 1985. PMID: 2409654